Advanced search
Publication Cover
Molecular and Cellular Biology Volume 18, 1998 - Issue 12
Submit an article Journal homepage
51
Views
384
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO

Vania Gelmettib Department of Experimental Oncology, European Institute of Oncology, Milan20141, Italy
,
Jinsong Zhangb Department of Experimental Oncology, European Institute of Oncology, Milan20141, Italy;a Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and Departments of Genetics and Biochemistry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104
,
Mirco Fanellib Department of Experimental Oncology, European Institute of Oncology, Milan20141, Italy
,
Saverio Minuccib Department of Experimental Oncology, European Institute of Oncology, Milan20141, ItalyCorrespondence[email protected]
,
Pier Giuseppe Peliccib Department of Experimental Oncology, European Institute of Oncology, Milan20141, ItalyCorrespondence[email protected]
&
Mitchell A. Lazarb Department of Experimental Oncology, European Institute of Oncology, Milan20141, Italy;a Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and Departments of Genetics and Biochemistry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104Correspondence[email protected]
Pages 7185-7191 | Received 01 Jul 1998, Accepted 03 Sep 1998, Published online: 28 Mar 2023

Citations (384)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (30)

Maximilian Stahl, Steven D. Gore, Norbert Vey & Thomas Prebet. (2016) Lost in translation? Ten years of development of histone deacetylase inhibitors in acute myeloid leukemia and myelodysplastic syndromes. Expert Opinion on Investigational Drugs 25:3, pages 307-317.
Read now
Francesca Buchi, Erico Masala, Alessia Rossi, Ana Valencia, Elena Spinelli, Alessandro Sanna, Antonella Gozzini & Valeria Santini. (2014) Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. Epigenetics 9:3, pages 387-395.
Read now
Valentina Barbetti, Antonella Gozzini, Giulia Cheloni, Ilaria Marzi, Emiliano Fabiani, Valeria Santini, Persio Dello Sbarba & Elisabetta Rovida. (2013) Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells. Epigenetics 8:2, pages 210-219.
Read now
Aubrey Hunt, Melissa Fischer, Michael E. Engel & Scott W. Hiebert. (2011) Mtg16/Eto2 Contributes to Murine T-Cell Development. Molecular and Cellular Biology 31:13, pages 2544-2551.
Read now
Christopher D Watt & Adam Bagg. (2010) Molecular diagnosis of acute myeloid leukemia. Expert Review of Molecular Diagnostics 10:8, pages 993-1012.
Read now
Chun Guo, Qiande Hu, Chunxia Yan & Jinsong Zhang. (2009) Multivalent Binding of the ETO Corepressor to E Proteins Facilitates Dual Repression Controls Targeting Chromatin and the Basal Transcription Machinery. Molecular and Cellular Biology 29:10, pages 2644-2657.
Read now
Brenda J. Chyla, Isabel Moreno-Miralles, Melissa A. Steapleton, Mary Ann Thompson, Srividya Bhaskara, Michael Engel & Scott W. Hiebert. (2008) Deletion of Mtg16, a Target of t(16;21), Alters Hematopoietic Progenitor Cell Proliferation and Lineage Allocation. Molecular and Cellular Biology 28:20, pages 6234-6247.
Read now
Daniela Salat, Robert Liefke, Jörg Wiedenmann, Tilman Borggrefe & Franz Oswald. (2008) ETO, but Not Leukemogenic Fusion Protein AML1/ETO, Augments RBP-Jκ/SHARP-Mediated Repression of Notch Target Genes. Molecular and Cellular Biology 28:10, pages 3502-3512.
Read now
Amy C. Moore, Joseph M. Amann, Christopher S. Williams, Emilios Tahinci, Tiffany E. Farmer, J. Andres Martinez, Genyan Yang, K. Scott Luce, Ethan Lee & Scott W. Hiebert. (2008) Myeloid Translocation Gene Family Members Associate with T-Cell Factors (TCFs) and Influence TCF-Dependent Transcription. Molecular and Cellular Biology 28:3, pages 977-987.
Read now
Antonello Mai. (2007) The therapeutic uses of chromatin-modifying agents. Expert Opinion on Therapeutic Targets 11:6, pages 835-851.
Read now
Joseph M. Amann, Brenda J. Irvin Chyla, Tiffany C. Ellis, Andres Martinez, Amy C. Moore, Jeffrey L. Franklin, Laura McGhee, Shari Meyers, Joyce E. Ohm, K. Scott Luce, Andre J. Ouelette, M. Kay Washington, Mary Ann Thompson, Dana King, Shiva Gautam, Robert J. Coffey, Robert H. Whitehead & Scott W. Hiebert. (2005) Mtgr1 Is a Transcriptional Corepressor That Is Required for Maintenance of the Secretory Cell Lineage in the Small Intestine. Molecular and Cellular Biology 25:21, pages 9576-9585.
Read now
J. C. Young, S. Wu, G. Hansteen, C. Du, L. Sambucetti, S. Remiszewski, A-M. O'Farrell, B. Hill, C. Lavau & L. J. Murray. (2004) Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy 6:4, pages 328-336.
Read now
Francesco Piazza & Gianpietro Semenzato. (2004) Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction. Expert Review of Anticancer Therapy 4:3, pages 387-400.
Read now
Carsten Müller-Tidow, Björn Steffen, Thomas Cauvet, Lara Tickenbrock, Ping Ji, Sven Diederichs, Bülent Sargin, Gabriele Köhler, Matthias Stelljes, Elena Puccetti, Martin Ruthardt, Sven deVos, Scott W. Hiebert, H. Phillip Koeffler, Wolfgang E. Berdel & Hubert Serve. (2004) Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells. Molecular and Cellular Biology 24:7, pages 2890-2904.
Read now
Kristie L. Durst, Bart Lutterbach, Tanawan Kummalue, Alan D. Friedman & Scott W. Hiebert. (2003) The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain. Molecular and Cellular Biology 23:2, pages 607-619.
Read now
Joëlle Michaud, Hamish S. Scott & Robert Escher. (2003) AML1 Interconnected Pathways of Leukemogenesis. Cancer Investigation 21:1, pages 105-136.
Read now
Tanawan Kummalue, Jianrong Lou & Alan D. Friedman. (2002) Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBFβ-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein. Molecular and Cellular Biology 22:23, pages 8278-8291.
Read now
Joseph M. Amann, John Nip, David K. Strom, Bart Lutterbach, Hironori Harada, Noel Lenny, James R. Downing, Shari Meyers & Scott W. Hiebert. (2001) ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain. Molecular and Cellular Biology 21:19, pages 6470-6483.
Read now
Franco Calabi, Richard Pannell & Gordana Pavloska. (2001) Gene Targeting Reveals a Crucial Role forMTG8 in the Gut. Molecular and Cellular Biology 21:16, pages 5658-5666.
Read now
Sebastien A. Burel, Nari Harakawa, Liming Zhou, Thomas Pabst, Daniel G. Tenen & Dong-Er Zhang. (2001) Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation. Molecular and Cellular Biology 21:16, pages 5577-5590.
Read now
Mukul Mathur, Philip W. Tucker & Herbert H. Samuels. (2001) PSF Is a Novel Corepressor That Mediates Its Effect through Sin3A and the DNA Binding Domain of Nuclear Hormone Receptors. Molecular and Cellular Biology 21:7, pages 2298-2311.
Read now
V. Sontini, A. Gozzini, B. Scappini, A. Grossi & P. Rossi Ferrini. (2001) Searching for the Magic Bullet Against Cancer: The Butyrate Saga. Leukemia & Lymphoma 42:3, pages 275-289.
Read now
Tokiko Nagamura-Inoue, Tomohiko Tamura & Keiko Ozato. (2001) Transcription Factors that Regulate Growth and Differentiation of Myeloid Cells. International Reviews of Immunology 20:1, pages 83-105.
Read now
Jinsong Zhang, Bruce A. Hug, Eric Y. Huang, Clarice W. Chen, Vania Gelmetti, Marco Maccarana, Saverio Minucci, Pier Giuseppe Pelicci & Mitchell A. Lazar. (2001) Oligomerization of ETO Is Obligatory for Corepressor Interaction. Molecular and Cellular Biology 21:1, pages 156-163.
Read now
James DiRenzo, Yongfeng Shang, Michael Phelan, Säid Sif, Molly Myers, Robert Kingston & Myles Brown. (2000) BRG-1 Is Recruited to Estrogen-Responsive Promoters and Cooperates with Factors Involved in Histone Acetylation. Molecular and Cellular Biology 20:20, pages 7541-7549.
Read now
Suming Huang & Stephen J. Brandt. (2000) mSin3A Regulates Murine Erythroleukemia Cell Differentiation through Association with the TAL1 (or SCL) Transcription Factor. Molecular and Cellular Biology 20:6, pages 2248-2259.
Read now
Ari M. Melnick, Jennifer J. Westendorf, Adam Polinger, Graeme W. Carlile, Sally Arai, Helen J. Ball, Bart Lutterbach, Scott W. Hiebert & Jonathan D. Licht. (2000) The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein. Molecular and Cellular Biology 20:6, pages 2075-2086.
Read now
Jürgen Krauter, Gerhard Heil & Arnold Ganser. (2000) The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease. Hematology 5:5, pages 369-381.
Read now
Jinsong Zhang, Xiao Hu & Mitchell A. Lazar. (1999) A Novel Role for Helix 12 of Retinoid X Receptor in Regulating Repression. Molecular and Cellular Biology 19:9, pages 6448-6457.
Read now
Judith E Karp & Clarence B Sarkodee-Adoo. (1999) Acute progranulocytic leukaemia: a model for molecular medicine. Emerging Therapeutic Targets 3:1, pages 135-150.
Read now

Articles from other publishers (354)

Ugo Chianese, Chiara Papulino, Wout Megchelenbrink, Francesco Paolo Tambaro, Fortunato Ciardiello, Rosaria Benedetti & Lucia Altucci. (2023) Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives. Seminars in Cancer Biology 92, pages 84-101.
Crossref
Peggy Kanellou, Ilias Georgakopoulos-Soares & Apostolos Zaravinos. (2023) Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients. Cancers 15:6, pages 1795.
Crossref
Ian M. Bouligny, Keri R. Maher & Steven Grant. (2023) Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives. Blood Reviews 57, pages 100996.
Crossref
Kriti Kushwaha, Sourbh Suren Garg & Jeena Gupta. (2022) Targeting epigenetic regulators for treating diabetic nephropathy. Biochimie 202, pages 146-158.
Crossref
Claudia Chiriches, Nathalie Nicolaisen, Maria Wieske, Heba Elhaddad, Ecmel Mehmetbeyoglu, Caroline Alvares, Dörte Becher, Paul Hole, Oliver Gerhard Ottmann & Martin Ruthardt. (2022) Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. PLOS Genetics 18:10, pages e1010463.
Crossref
Yi-Fan Zhang, Xiao-Lin Wang, Chun-Hui Xu, Na Liu, Ling Zhang, Yu-Ming Zhang, Yin-Yin Xie, Yuan-Liang Zhang, Qiu-Hua Huang, Lan Wang, Zhu Chen, Sai-Juan Chen, Robert G. Roeder, Shuhong Shen, Kai Xue & Xiao-Jian Sun. (2022) A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation. Frontiers in Cell and Developmental Biology 10.
Crossref
Jessica L. Dennison, Hassan Al-Ali, Claude-Henry Volmar, Shaun Brothers, Justin Watts, Claes Wahlestedt & Ines Lohse. (2022) Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers 14:17, pages 4094.
Crossref
Yulieth Ximena Torres-Llanos & Alba Lucia Combita-Rojas. (2022) Relation between tumor micro-environment and epigenetic alterations in hematological malignancies. Advances in Cancer Biology - Metastasis 4, pages 100024.
Crossref
Rachel E. Brown, Justin Jacobse, Shruti A. Anant, Koral M. Blunt, Bob Chen, Paige N. Vega, Chase T. Jones, Jennifer M. Pilat, Frank Revetta, Aidan H. Gorby, Kristy R. Stengel, Yash A. Choksi, Kimmo Palin, M. Blanca Piazuelo, Mary Kay Washington, Ken S. Lau, Jeremy A. Goettel, Scott W. Hiebert, Sarah P. Short & Christopher S. Williams. (2022) MTG16 regulates colonic epithelial differentiation, colitis, and tumorigenesis by repressing E protein transcription factors. JCI Insight 7:10.
Crossref
Tomofusa Fukuyama, Toshio Kitamura & Tomoko Kozu. (2022) UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8. International Journal of Hematology 115:5, pages 686-693.
Crossref
Gabriela Krivdova, Veronique Voisin, Erwin M. Schoof, Sajid A. Marhon, Alex Murison, Jessica L. McLeod, Martino M. Gabra, Andy G.X. Zeng, Stefan Aigner, Brian A. Yee, Alexander A. Shishkin, Eric L. Van Nostrand, Karin G. Hermans, Aaron C. Trotman-Grant, Nathan Mbong, James A. Kennedy, Olga I. Gan, Elvin Wagenblast, Daniel D. De Carvalho, Leonardo Salmena, Mark D. Minden, Gary D. Bader, Gene W. Yeo, John E. Dick & Eric R. Lechman. (2022) Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML. Cell Reports 38:10, pages 110481.
Crossref
Elmira Vagapova, Maxim Kozlov, Timofey Lebedev, Karina Ivanenko, Olga Leonova, Vladimir Popenko, Pavel Spirin, Sergey Kochetkov & Vladimir Prassolov. (2021) Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs. Biomedicines 9:12, pages 1846.
Crossref
Daniel T. Johnson, Amanda G. Davis, Jie-Hua Zhou, Edward D. Ball & Dong-Er Zhang. (2021) MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR. Experimental Hematology & Oncology 10:1.
Crossref
Bon Q. TrinhSimone Ummarino, Yanzhou ZhangAlexander K. EbralidzeMahmoud A. Bassal, Tuan M. NguyenGerwin HellerRory CoffeyDanielle E. TenenEmiel van der KouweEmiliano Fabiani, Carmelo Gurnari, Chan-Shuo WuVladimir Espinosa Angarica, Henry YangSisi ChenHong ZhangAbby R. Thurm, Francisco Marchi, Elena Levantini, Philipp B. StaberPu ZhangMaria Teresa Voso, Pier Paolo PandolfiSusumu S. KobayashiLi Chai, Annalisa Di Ruscio & Daniel G. Tenen. (2021) Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML . Blood 138:15, pages 1331-1344.
Crossref
Kai Rejeski, Jesús Duque-Afonso & Michael Lübbert. (2021) AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms. Oncogene 40:38, pages 5665-5676.
Crossref
Snigdha Saikia, Uttariya Pal, Deep Jyoti Kalita, Avdhesh Kumar Rai, Anupam Sarma, Amal Chandra Kataki & Anil Mukund Limaye. (2021) RUNX1T1, a potential prognostic marker in breast cancer, is co-ordinately expressed with ERα, and regulated by estrogen receptor signalling in breast cancer cells. Molecular Biology Reports 48:7, pages 5399-5409.
Crossref
Katelyn E. Heimbruch, Alison E. Meyer, Puja Agrawal, Aaron D. Viny & Sridhar Rao. (2021) A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML. Neoplasia 23:3, pages 337-347.
Crossref
Kristy R. Stengel, Jacob D. Ellis, Clare L. Spielman, Monica L. Bomber & Scott W. Hiebert. (2021) Definition of a small core transcriptional circuit regulated by AML1-ETO. Molecular Cell 81:3, pages 530-545.e5.
Crossref
Laura E. Swart & Olaf Heidenreich. (2021) The RUNX1/RUNX1T1 network: translating insights into therapeutic options. Experimental Hematology 94, pages 1-10.
Crossref
Benedetto Daniele Giaimo, Ellen K. Gagliani, Rhett A. Kovall & Tilman Borggrefe. 2021. Notch Signaling in Embryology and Cancer. Notch Signaling in Embryology and Cancer 9 30 .
Linqing Zou, Haoming Li, Xiao Han, Jianbing Qin & Guoqi Song. (2020) Runx1t1 promotes the neuronal differentiation in rat hippocampus. Stem Cell Research & Therapy 11:1.
Crossref
Pan Wang, Zi Wang & Jing Liu. (2020) Role of HDACs in normal and malignant hematopoiesis. Molecular Cancer 19:1.
Crossref
Min Young Kim, Bowen Yan, Suming Huang & Yi Qiu. (2020) Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis. International Journal of Molecular Sciences 21:22, pages 8460.
Crossref
Junichi Fukunaga, Yusuke Nomura, Yoichiro Tanaka, Hidetaka Torigoe, Yoshikazu Nakamura, Taiichi Sakamoto & Tomoko Kozu. (2020) A G‐quadruplex‐forming RNA aptamer binds to the MTG8 TAFH domain and dissociates the leukemic AML1‐MTG8 fusion protein from DNA. FEBS Letters 594:21, pages 3477-3489.
Crossref
Lourdes Hontecillas-Prieto, Rocío Flores-Campos, Andrew Silver, Enrique de Álava, Nabil Hajji & Daniel J. García-Domínguez. (2020) Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials. Frontiers in Genetics 11.
Crossref
Nickolas Steinauer, Chun Guo & Jinsong Zhang. (2020) The transcriptional corepressor CBFA2T3 inhibits all-trans-retinoic acid–induced myeloid gene expression and differentiation in acute myeloid leukemia. Journal of Biological Chemistry 295:27, pages 8887-8900.
Crossref
Chun Guo, Jian Li, Nickolas Steinauer, Madeline Wong, Brent Wu, Alexandria Dickson, Markus Kalkum & Jinsong Zhang. (2020) Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1–ETO–dependent transcription in t(8;21) AML. Journal of Biological Chemistry 295:13, pages 4212-4223.
Crossref
Sayer Al-Harbi, Mahmoud Aljurf, Mohamad Mohty, Fahad Almohareb & Syed Osman Ali Ahmed. (2020) An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1. Blood Advances 4:1, pages 229-238.
Crossref
Caroline Schoenherr, Katharina Wohlan, Iris Dallmann, Andreas Pich, Jan Hegermann, Arnold Ganser, Denise Hilfiker-Kleiner, Olaf Heidenreich, Michaela Scherr & Matthias Eder. (2019) Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase. PLOS ONE 14:12, pages e0225977.
Crossref
Orsola di Martino & John S. Welch. (2019) Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy. Cancers 11:12, pages 1915.
Crossref
Julie A. I. Thoms, Dominik Beck & John E. Pimanda. (2019) Transcriptional networks in acute myeloid leukemia. Genes, Chromosomes and Cancer 58:12, pages 859-874.
Crossref
Deli Hong, Andrew J. Fritz, Jonathan A. Gordon, Coralee E. Tye, Joseph R. Boyd, Kirsten M. Tracy, Seth E. Frietze, Frances E. Carr, Jeffrey A. Nickerson, Andre J. Van Wijnen, Anthony N. Imbalzano, Sayyed K. Zaidi, Jane B. Lian, Janet L. Stein & Gary S. Stein. (2018) RUNX1‐dependent mechanisms in biological control and dysregulation in cancer. Journal of Cellular Physiology 234:6, pages 8597-8609.
Crossref
Shilpa Sampathi, Pankaj Acharya, Yue Zhao, Jing Wang, Kristy R Stengel, Qi Liu, Michael R Savona & Scott W Hiebert. (2019) The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5′ and 3′ ends of genes. Nucleic Acids Research 47:8, pages 3921-3936.
Crossref
Mylène Gerritsen, Guoqiang YiEsther TijchonJorren KusterJan Jacob Schuringa, Joost H. A. MartensEdo Vellenga. (2019) RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs. Blood Advances 3:3, pages 320-332.
Crossref
Emiel van der Kouwe & Philipp Staber. (2019) RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia. International Journal of Molecular Sciences 20:2, pages 350.
Crossref
Na LiuJunhong SongYangyang XieXiao-Lin WangBowen RongNa ManMeng-Meng ZhangQunling ZhangFei-Fei GaoMei-Rong DuYing ZhangJian ShenChun-Hui XuCheng-Long HuJi-Chuan WuPing LiuYuan-Liang ZhangYin-Yin XiePing LiuJin-Yan Huang, Qiu-Hua HuangFei LanShuhong ShenStephen D. NimerZhu ChenSai-Juan ChenRobert G. Roeder, Lan WangXiao-Jian Sun. (2018) Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis. Proceedings of the National Academy of Sciences 116:3, pages 890-899.
Crossref
Clayton E. Kibler, Sarah L. Milligan, Tierra R. Farris, Bing Zhu, Shubhajit Mitra & Jere W. McBride. (2018) Ehrlichia chaffeensis TRP47 enters the nucleus via a MYND-binding domain-dependent mechanism and predominantly binds enhancers of host genes associated with signal transduction, cytoskeletal organization, and immune response. PLOS ONE 13:11, pages e0205983.
Crossref
Natalia Martinez-Soria, Lynsey McKenzie, Julia Draper, Anetta Ptasinska, Hasan Issa, Sandeep Potluri, Helen J. Blair, Anna Pickin, Asmida Isa, Paulynn Suyin Chin, Ricky Tirtakusuma, Daniel Coleman, Sirintra Nakjang, Salam Assi, Victoria Forster, Mojgan Reza, Ed Law, Philip Berry, Dorothee Mueller, Cameron Osborne, Alex Elder, Simon N. Bomken, Deepali Pal, James M. Allan, Gareth J. Veal, Peter N. Cockerill, Christian Wichmann, Josef Vormoor, Georges Lacaud, Constanze Bonifer & Olaf Heidenreich. (2018) The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation. Cancer Cell 34:4, pages 626-642.e8.
Crossref
Charles A. S. Banks, Sayem Miah, Mark K. Adams, Cassandra G. Eubanks, Janet L. Thornton, Laurence Florens & Michael P. Washburn. (2018) Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly. Scientific Reports 8:1.
Crossref
Ashley A. Newcombe, Brenda E.S. Gibson & Karen Keeshan. (2018) Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia. Experimental Hematology 63, pages 1-11.
Crossref
Justin Loke, Paulynn Suyin Chin, Peter Keane, Anna Pickin, Salam A. Assi, Anetta Ptasinska, Maria Rosaria Imperato, Peter N. Cockerill & Constanze Bonifer. (2018) C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia. Blood Advances 2:3, pages 271-284.
Crossref
Kenta Takada, Ryo Amano, Yusuke Nomura, Yoichiro Tanaka, Shigeru Sugiyama, Takashi Nagata, Masato Katahira, Yoshikazu Nakamura, Tomoko Kozu & Taiichi Sakamoto. (2018) Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses. FEBS Open Bio 8:2, pages 264-270.
Crossref
Amir Hosseini & Saverio Minucci. 2018. Epigenetics in Human Disease. Epigenetics in Human Disease 141 217 .
J. N. Nichol, M. Kinal & W. H. MillerJr.Jr.. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 161 177 .
Tan Boon Toh, Jhin Jieh Lim & Edward Kai-Hua Chow. (2017) Epigenetics in cancer stem cells. Molecular Cancer 16:1.
Crossref
V N Thiel, B D Giaimo, P Schwarz, K Soller, V Vas, M Bartkuhn, T J Blätte, K Döhner, L Bullinger, T Borggrefe, H Geiger & F Oswald. (2017) Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation. Leukemia 31:11, pages 2491-2502.
Crossref
Danielle C. Desravines, Itziar Serna Martin, Robert Schneider, Philippe J. Mas, Nataliia Aleksandrova, Malene Ringkjøbing Jensen, Martin Blackledge & Darren J. Hart. (2017) Structural Characterization of the SMRT Corepressor Interacting with Histone Deacetylase 7. Scientific Reports 7:1.
Crossref
Raman Sood, Yasuhiko Kamikubo & Paul Liu. (2017) Role of RUNX1 in hematological malignancies. Blood 129:15, pages 2070-2082.
Crossref
Nickolas Steinauer, Chun Guo & Jinsong Zhang. (2017) Emerging Roles of MTG16 in Cell-Fate Control of Hematopoietic Stem Cells and Cancer. Stem Cells International 2017, pages 1-12.
Crossref
Tahir H. Tahirov & John Bushweller. 2017. RUNX Proteins in Development and Cancer. RUNX Proteins in Development and Cancer 21 31 .
Shan Lin, James C. Mulloy & Susumu Goyama. 2017. RUNX Proteins in Development and Cancer. RUNX Proteins in Development and Cancer 151 173 .
Ryo Amano, Kenta Takada, Yoichiro Tanaka, Yoshikazu Nakamura, Gota Kawai, Tomoko Kozu & Taiichi Sakamoto. (2016) Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein. Biochemistry 55:45, pages 6221-6229.
Crossref
Alokta Chakrabarti, Jelena Melesina, Fiona R Kolbinger, Ina Oehme, Johanna Senger, Olaf Witt, Wolfgang Sippl & Manfred Jung. (2016) Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases. Future Medicinal Chemistry 8:13, pages 1609-1634.
Crossref
Kevin A. LinkShan LinMahesh ShresthaMelissa BowmanMark WunderlichClara D. BloomfieldGang Huang & James C. Mulloy. (2016) Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation. Proceedings of the National Academy of Sciences 113:32, pages 9075-9080.
Crossref
Jian Li, Chun Guo, Nickolas Steinauer & Jinsong Zhang. (2016) New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins. Frontiers in Biology 11:4, pages 285-304.
Crossref
B A Vishwakarma, N Nguyen, H Makishima, N Hosono, K O Gudmundsson, V Negi, K Oakley, Y Han, B Przychodzen, J P Maciejewski & Y Du. (2015) Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development. Leukemia 30:1, pages 200-208.
Crossref
Daniel J Trombly, Troy W Whitfield, Srivatsan Padmanabhan, Jonathan AR Gordon, Jane B Lian, Andre J van Wijnen, Sayyed K Zaidi, Janet L Stein & Gary S Stein. (2015) Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells. BMC Genomics 16:1.
Crossref
Franck Morceau, Sébastien Chateauvieux, Marion Orsini, Anne Trécul, Mario Dicato & Marc Diederich. (2015) Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathways. Biotechnology Advances 33:6, pages 785-797.
Crossref
Mo Chen, Nan Zhu, Xiaochuan Liu, Benoit Laurent, Zhanyun Tang, Rowena Eng, Yang Shi, Scott A. Armstrong & Robert G. Roeder. (2015) JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors. Genes & Development 29:20, pages 2123-2139.
Crossref
Kate H. Brettingham-Moore, Phillippa C. Taberlay & Adele F. Holloway. (2015) Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia. Frontiers in Immunology 6.
Crossref
Ferdinando ChiaradonnaClaudia CirulliRoberta PaloriniGiuseppina VottaLilia Alberghina. (2015) New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer. Antioxidants & Redox Signaling 23:1, pages 30-50.
Crossref
Rosaria BenedettiMariarosaria ConteLucia Altucci. (2015) Targeting Histone Deacetylases in Diseases: Where Are We?. Antioxidants & Redox Signaling 23:1, pages 99-126.
Crossref
Pusoon Chun. (2015) Histone deacetylase inhibitors in hematological malignancies and solid tumors. Archives of Pharmacal Research 38:6, pages 933-949.
Crossref
Parveen Kumar, Urban Gullberg, Inge Olsson & Ram Ajore. (2015) Myeloid Translocation Gene-16 Co-Repressor Promotes Degradation of Hypoxia-Inducible Factor 1. PLOS ONE 10:5, pages e0123725.
Crossref
Zou Linqing, Jin Guohua, Li HaomingTao XueleiQin JianbingTian Meiling. (2015) Runx1t1 Regulates the Neuronal Differentiation of Radial Glial Cells From the Rat Hippocampus. Stem Cells Translational Medicine 4:1, pages 110-116.
Crossref
Thomas B. Nicholson, Nicolas Veland & Taiping Chen. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy 31 66 .
Christopher J. Millard & John W. R. Schwabe. 2015. Nuclear Receptors: From Structure to the Clinic. Nuclear Receptors: From Structure to the Clinic 155 175 .
Margherita Ghisi & Ricky W. Johnstone. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia 411 439 .
Jonathan I. Sive & Berthold Göttgens. (2014) Transcriptional network control of normal and leukaemic haematopoiesis. Experimental Cell Research 329:2, pages 255-264.
Crossref
Melhem Solh, Sophia Yohe, Daniel Weisdorf & Celalettin Ustun. (2014) Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy. American Journal of Hematology 89:12, pages 1121-1131.
Crossref
De-Si Pan, Qian-Jiao Yang, Xin Fu, Song Shan, Jing-Zhong Zhu, Kun Zhang, Zhi-Bin Li, Zhi-Qiang Ning & Xian-Ping Lu. (2014) Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment. MedChemComm 5:12, pages 1789-1796.
Crossref
Jung-Hyun Kim & Eun-Young Erin Ahn. (2014) Transcript variants of RUNX1T1: New insight into t(8;21)-positive leukemia. Leukemia Research 38:9, pages 1018-1019.
Crossref
Dineo Khabele. (2014) The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer. Frontiers in Oncology 4.
Crossref
Shlomo Elias, Rachel YaminLior Golomb, Pinchas TsukermanNoah Stanietsky-KaynanDina Ben-Yehuda & Ofer Mandelboim. (2014) Immune evasion by oncogenic proteins of acute myeloid leukemia. Blood 123:10, pages 1535-1543.
Crossref
Michael BotsInge VerbruggeBenjamin P. MartinJessica M. SalmonMargherita GhisiAdele BakerKym StanleyJake ShorttGert J. OssenkoppeleJohannes ZuberAmy R. RappaportPeter Atadja, Scott W. LoweRicky W. Johnstone. (2014) Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. Blood 123:9, pages 1341-1352.
Crossref
Nimmi Baby, Yali Li, Eng-Ang Ling, Jia Lu & S. Thameem Dheen. (2014) Runx1t1 (Runt-Related Transcription Factor 1; Translocated to, 1) Epigenetically Regulates the Proliferation and Nitric Oxide Production of Microglia. PLoS ONE 9:2, pages e89326.
Crossref
ZHI-HUA ZHANG, CHANG-LAI HAO, PENG LIU, XIA TIAN, LI-HONG WANG, LEI ZHAO & CUI-MIN ZHU. (2014) Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi-1 leukemia cells. Molecular Medicine Reports 9:2, pages 443-449.
Crossref
Alison C. West & Ricky W. Johnstone. (2014) New and emerging HDAC inhibitors for cancer treatment. Journal of Clinical Investigation 124:1, pages 30-39.
Crossref
Chien-Hung Gow, Chun Guo, David Wang, Qiande Hu & Jinsong Zhang. (2014) Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways. Nucleic Acids Research 42:1, pages 137-152.
Crossref
José Marín-García. 2014. Post-Genomic Cardiology. Post-Genomic Cardiology 747 782 .
Jesús Duque-Afonso, Michael Lübbert & Michael L. Cleary. 2014. Epigenetic Therapy of Cancer. Epigenetic Therapy of Cancer 121 144 .
Keith E. Latham. 2014. Posttranslational Protein Modifications in the Reproductive System. Posttranslational Protein Modifications in the Reproductive System 141 158 .
Russell C. DeKelver, Benjamin Lewin, Kentson Lam, Yukiko Komeno, Ming Yan, Chandler Rundle, Miao-Chia Lo & Dong-Er Zhang. (2013) Cooperation between RUNX1-ETO9a and Novel Transcriptional Partner KLF6 in Upregulation of Alox5 in Acute Myeloid Leukemia. PLoS Genetics 9:10, pages e1003765.
Crossref
Grace L. Peloquin, Yi-Bin Chen & Amir T. Fathi. (2013) The evolving landscape in the therapy of acute myeloid leukemia. Protein & Cell 4:10, pages 735-746.
Crossref
Xiao-Jian Sun, Zhanxin Wang, Lan Wang, Yanwen Jiang, Nils Kost, T. David Soong, Wei-Yi Chen, Zhanyun Tang, Tomoyoshi Nakadai, Olivier Elemento, Wolfgang Fischle, Ari Melnick, Dinshaw J. Patel, Stephen D. Nimer & Robert G. Roeder. (2013) A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis. Nature 500:7460, pages 93-97.
Crossref
Parveen Kumar, Vladimir V. Sharoyko, Peter Spégel, Urban Gullberg, Hindrik Mulder, Inge Olsson & Ram Ajore. (2013) The Transcriptional Co-Repressor Myeloid Translocation Gene 16 Inhibits Glycolysis and Stimulates Mitochondrial Respiration. PLoS ONE 8:7, pages e68502.
Crossref
Russell C. DeKelverMing YanEun-Young AhnWei-Jong ShiaNancy A. Speck & Dong-Er Zhang. (2013) Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential. Blood 121:18, pages 3714-3717.
Crossref
Yong Cheng, John Gaughan, Uros Midic, Zhiming Han, Cheng-Guang Liang, Bela G Patel & Keith E Latham. (2013) Systems Genetics Implicates Cytoskeletal Genes in Oocyte Control of Cloned Embryo Quality. Genetics 193:3, pages 877-896.
Crossref
J E Bolden, W Shi, K Jankowski, C-Y Kan, L Cluse, B P Martin, K L MacKenzie, G K Smyth & R W Johnstone. (2013) HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses. Cell Death & Disease 4:2, pages e519-e519.
Crossref
Fatiha Kateb, Helene Perrin, Konstantinos Tripsianes, Peijian Zou, Roberta Spadaccini, Matthew Bottomley, Titus M. Franzmann, Johannes Buchner, Stephane Ansieau & Michael Sattler. (2013) Structural and Functional Analysis of the DEAF-1 and BS69 MYND Domains. PLoS ONE 8:1, pages e54715.
Crossref
Stefano Rossetti & Nicoletta Sacchi. (2013) RUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis. International Journal of Molecular Sciences 14:1, pages 1566-1588.
Crossref
Jessica N. Nichol, Sarit Assouline & Wilson H. Miller. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 177 198 .
Elizabeth A. Griffiths & Steven D. Gore. 2013. Epigenetic Alterations in Oncogenesis. Epigenetic Alterations in Oncogenesis 253 283 .
Joost H. A. MartensAmit MandoliFemke SimmerBart-Jan WierengaSadia SaeedAbhishek A. SinghLucia Altucci, Edo VellengaHendrik G. Stunnenberg. (2012) ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia. Blood 120:19, pages 4038-4048.
Crossref
E. N. Markova, N. V. Petrova, S. V. Razin & O. L. Kantidze. (2012) Transcription factor RUNX1. Molecular Biology 46:6, pages 755-767.
Crossref
Yuki Kagiyama, Jiro Kitaura, Katsuhiro Togami, Tomoyuki Uchida, Daichi Inoue, Toshihiro Matsukawa, Kumi Izawa, Kimihito C. Kawabata, Yukiko Komeno, Toshihiko Oki, Fumio Nakahara, Katsuaki Sato, Hiroyuki Aburatani & Toshio Kitamura. (2012) Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice. International Journal of Hematology 96:5, pages 638-648.
Crossref
Megan A. Hatlen, Lan Wang & Stephen D. Nimer. (2012) AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches. Frontiers of Medicine 6:3, pages 248-262.
Crossref
A Ptasinska, S A Assi, D Mannari, S R James, D Williamson, J Dunne, M Hoogenkamp, M Wu, M Care, H McNeill, P Cauchy, M Cullen, R M Tooze, D G Tenen, B D Young, P N Cockerill, D R Westhead, O Heidenreich & C Bonifer. (2012) Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia 26:8, pages 1829-1841.
Crossref
Tanja A. Gruber & James R. Downing. 2013. Childhood Leukemias. Childhood Leukemias 204 238 .
A Maiques-Diaz, F S Chou, M Wunderlich, G Gómez-López, F V Jacinto, S Rodriguez-Perales, M J Larrayoz, M J Calasanz, J C Mulloy, J C Cigudosa & S Alvarez. (2012) Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs. Leukemia 26:6, pages 1329-1337.
Crossref
A Seshire, T Rößiger, M Frech, S Beez, H Hagemeyer & E Puccetti. (2011) Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding. Leukemia 26:6, pages 1338-1347.
Crossref
Jasmine Zain. (2012) Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma. Hematology/Oncology Clinics of North America 26:3, pages 671-704.
Crossref
Michal Zapotocky, Ester Mejstrikova, Karel Smetana, Jan Stary, Jan Trka & Julia Starkova. (2012) Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically. Cancer Letters 319:2, pages 144-153.
Crossref
Wei-Jong ShiaAkiko J. OkumuraMing YanAli SarkeshikMiao-Chia LoShinobu MatsuuraYukiko KomenoXinyang Zhao, Stephen D. Nimer, John R. YatesIIIIIIDong-Er Zhang. (2012) PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential. Blood 119:21, pages 4953-4962.
Crossref
Melissa A Fischer, Isabel Moreno-Miralles, Aubrey Hunt, Brenda J Chyla & Scott W Hiebert. (2012) Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence. The EMBO Journal 31:6, pages 1494-1505.
Crossref
Ching-Pin ChangBenoit G. Bruneau. (2012) Epigenetics and Cardiovascular Development. Annual Review of Physiology 74:1, pages 41-68.
Crossref
Heidi J. NickHyung-Gyoon KimChia-Wei ChangKevin W. Harris, Vishnu Reddy & Christopher A. Klug. (2012) Distinct classes of c-Kit–activating mutations differ in their ability to promote RUNX1-ETO–associated acute myeloid leukemia. Blood 119:6, pages 1522-1531.
Crossref
Roel H. Wilting & Jan-Hermen Dannenberg. (2012) Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Drug Resistance Updates 15:1-2, pages 21-38.
Crossref
Peter J. Watson, Louise Fairall & John W.R. Schwabe. (2012) Nuclear hormone receptor co-repressors: Structure and function. Molecular and Cellular Endocrinology 348:2, pages 440-449.
Crossref
Ciro Mercurio, Simon Plyte & Saverio Minucci. 2012. Epigenetics in Human Disease. Epigenetics in Human Disease 53 87 .
Vu Duong & Jeffrey Lancet. 2012. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics 315 348 .
Shinichiro Takahashi. (2011) Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications. Journal of Hematology & Oncology 4:1.
Crossref
Yutaka Shima & Issay Kitabayashi. (2011) Deregulated transcription factors in leukemia. International Journal of Hematology 94:2, pages 134-141.
Crossref
Susumu Goyama & James C. Mulloy. (2011) Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects. International Journal of Hematology 94:2, pages 126-133.
Crossref
J Duque-Afonso, A Yalcin, T Berg, M Abdelkarim, O Heidenreich & M Lübbert. (2011) The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO. Oncogene 30:27, pages 3062-3072.
Crossref
Jesús Duque-Afonso, Leticia Solari, Aitomi Essig, Tobias Berg, Heike L. Pahl & Michael Lübbert. (2011) Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiation. British Journal of Haematology 153:5, pages 612-622.
Crossref
Pei HanCalvin T. HangJin YangChing-Pin Chang. (2011) Chromatin Remodeling in Cardiovascular Development and Physiology. Circulation Research 108:3, pages 378-396.
Crossref
Jasmeen Oberoi, Louise Fairall, Peter J Watson, Ji-Chun Yang, Zsolt Czimmerer, Thorsten Kampmann, Benjamin T Goult, Jacquie A Greenwood, John T Gooch, Bettina C Kallenberger, Laszlo Nagy, David Neuhaus & John W R Schwabe. (2011) Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery. Nature Structural & Molecular Biology 18:2, pages 177-184.
Crossref
A Quintás-Cardama, F P S Santos & G Garcia-Manero. (2010) Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia. Leukemia 25:2, pages 226-235.
Crossref
I. Uribesalgo & L. Di Croce. (2011) Dynamics of epigenetic modifications in leukemia. Briefings in Functional Genomics 10:1, pages 18-29.
Crossref
Weipeng Mu, Robert J. Munroe, Anna K. Barker & John C. Schimenti. (2010) PDCD2 is essential for inner cell mass development and embryonic stem cell maintenance. Developmental Biology 347:2, pages 279-288.
Crossref
A Gessner, M Thomas, P Garrido Castro, L Büchler, A Scholz, T H Brümmendorf, N Martinez Soria, J Vormoor, J Greil & O Heidenreich. (2010) Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT. Leukemia 24:10, pages 1751-1759.
Crossref
Laura Pedranzini, Federica Mottadelli, Simona Ronzoni, Franca Rossella, Manuela Ferracin, Ivana Magnani, Gaia Roversi, Patrizia Colapietro, Massimo Negrini, Pier Giuseppe Pelicci & Lidia Larizza. (2010) Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38− compartment. Leukemia Research 34:10, pages 1287-1295.
Crossref
Phillippa C. Oakford, Sally R. James, Abeer Qadi, Alison C. West, Shannon N. Ray, Andrew G. Bert, Peter N. Cockerill & Adele F. Holloway. (2010) Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1. Leukemia Research 34:9, pages 1203-1213.
Crossref
Takeshi Corpora, Liya Roudaia, Zaw Min Oo, Wei Chen, Ekaterina Manuylova, Xiongwei Cai, Michael J. Chen, Tomasz Cierpicki, Nancy A. Speck & John H. Bushweller. (2010) Structure of the AML1-ETO NHR3–PKA(RIIα) Complex and Its Contribution to AML1-ETO Activity. Journal of Molecular Biology 402:3, pages 560-577.
Crossref
Ciro Mercurio, Saverio Minucci & Pier Giuseppe Pelicci. (2010) Histone deacetylases and epigenetic therapies of hematological malignancies. Pharmacological Research 62:1, pages 18-34.
Crossref
D. Baskaran, P. V. Spirin & V. S. Prassolov. (2010) Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells. Molecular Biology 44:3, pages 369-379.
Crossref
Antonello Mai. (2010) Small-molecule chromatin-modifying agents: therapeutic applications. Epigenomics 2:2, pages 307-324.
Crossref
Jianjun Chen, Olatoyosi Odenike & Janet D. Rowley. (2010) Leukaemogenesis: more than mutant genes. Nature Reviews Cancer 10:1, pages 23-36.
Crossref
Aniruddha J. Deshpande, Christian Buske, Leticia Quintanilla-Martinez & Falko Fend. 2010. Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology of Hematolymphoid Diseases 3 19 .
Kevin A. Link, Fu-Sheng Chou & James C. Mulloy. (2010) Core binding factor at the crossroads: Determining the fate of the HSC. Journal of Cellular Physiology 222:1, pages 50-56.
Crossref
Gareth Brady & Paul J. Farrell. (2009) RUNX3-mediated repression of RUNX1 in B cells. Journal of Cellular Physiology 221:2, pages 283-287.
Crossref
Steven M. CorselloGiovanni RotiKenneth N. RossKwan T. ChowIlene Galinsky, Daniel J. DeAngelo, Richard M. Stone, Andrew L. KungTodd R. Golub & Kimberly Stegmaier. (2009) Identification of AML1-ETO modulators by chemical genomics. Blood 113:24, pages 6193-6205.
Crossref
Barbara Delage & Roderick Dashwood. 2009. Nutrients and Epigenetics. Nutrients and Epigenetics 127 154 .
Sangho ParkWei ChenTomasz CierpickiMarco TonelliXiongwei Cai, Nancy A. Speck & John H. Bushweller. (2009) Structure of the AML1-ETO eTAFH domain–HEB peptide complex and its contribution to AML1-ETO activity. Blood 113:15, pages 3558-3567.
Crossref
Liya RoudaiaMatthew D. CheneyEkaterina ManuylovaWei ChenMichelle MorrowSangho ParkChung-Tsai LeePrabhjot Kaur, Owen WilliamsJohn H. Bushweller & Nancy A. Speck. (2009) CBFβ is critical for AML1-ETO and TEL-AML1 activity. Blood 113:13, pages 3070-3079.
Crossref
Colin Kwok, Bernd B. Zeisig, Jihui Qiu, Shuo Dong & Chi Wai Eric So. (2009) Transforming activity of AML1-ETO is independent of CBFβ and ETO interaction but requires formation of homo-oligomeric complexes. Proceedings of the National Academy of Sciences 106:8, pages 2853-2858.
Crossref
Jennifer J. Clark, Jason N. Berman & A. Thomas Look. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood 331 402 .
Rakesh Singh Dhanda, Sofia Rondin Lindberg & Inge Olsson. (2008) The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues. BMC Molecular Biology 9:1.
Crossref
Alessandro Gardini, Matteo Cesaroni, Lucilla Luzi, Akiko J. Okumura, Joseph R. Biggs, Simone P. Minardi, Elisa Venturini, Dong-Er Zhang, Pier Giuseppe Pelicci & Myriam Alcalay. (2008) AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets. PLoS Genetics 4:11, pages e1000275.
Crossref
A M S Müller, J Duque, J A Shizuru & M Lübbert. (2008) Complementing mutations in core binding factor leukemias: from mouse models to clinical applications. Oncogene 27:44, pages 5759-5773.
Crossref
Isla Hamlett, Julia Draper, John Strouboulis, Francisco Iborra, Catherine Porcher & Paresh Vyas. (2008) Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation. Blood 112:7, pages 2738-2749.
Crossref
Akiko J. Okumura, Luke F. Peterson, Fumihiko Okumura, Anita Boyapati & Dong-Er Zhang. (2008) t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression. Blood 112:4, pages 1392-1401.
Crossref
Tiffany E. Farmer, Christopher S. Williams, M. Kay Washington & Scott W. Hiebert. (2008) Inactivation of the p19ARF tumor suppressor affects intestinal epithelial cell proliferation and integrity. Journal of Cellular Biochemistry 104:6, pages 2228-2240.
Crossref
Peter Paschka. (2008) Core Binding Factor Acute Myeloid Leukemia. Seminars in Oncology 35:4, pages 410-417.
Crossref
Raman Kumar, Kelly M. Cheney, Ross McKirdy, Paul M. Neilsen, Renèe B. Schulz, Jaclyn Lee, Juliane Cohen, Grant W. Booker & David F. Callen. (2008) CBFA2T3-ZNF652 Corepressor Complex Regulates Transcription of the E-box Gene HEB. Journal of Biological Chemistry 283:27, pages 19026-19038.
Crossref
Rose M. Ko, Hyung-Gyoon Kim, Linda Wolff & Christopher A. Klug. (2008) Roles of p15Ink4b and p16Ink4a in myeloid differentiation and RUNX1-ETO-associated acute myeloid leukemia. Leukemia Research 32:7, pages 1101-1111.
Crossref
Elena Serrano, Maria J. Carnicer, Adriana Lasa, Vanesa Orantes, Jorge Pena, Salut Brunet, Anna Aventín, Jorge Sierra & Josep F. Nomdedéu. (2008) Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias. Leukemia Research 32:6, pages 944-953.
Crossref
Srividya Bhaskara, Brenda J. Chyla, Joseph M. Amann, Sarah K. Knutson, David Cortez, Zu-Wen Sun & Scott W. Hiebert. (2008) Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control. Molecular Cell 30:1, pages 61-72.
Crossref
V Barbetti, A Gozzini, E Rovida, A Morandi, E Spinelli, G Fossati, P Mascagni, M Lübbert, P Dello Sbarba & V Santini. (2007) Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells. Oncogene 27:12, pages 1767-1778.
Crossref
Xinyang Zhao, Vladimir Jankovic, Alexander Gural, Gang Huang, Animesh Pardanani, Silvia Menendez, Jin Zhang, Richard Dunne, Andrew Xiao, Hediye Erdjument-Bromage, C. David Allis, Paul Tempst & Stephen D. Nimer. (2008) Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes & Development 22:5, pages 640-653.
Crossref
Virginia M. Klimek, Sophia Fircanis, Peter Maslak, Ilhem Guernah, Michael Baum, Nian Wu, Katherine Panageas, John J. Wright, Pier Paolo Pandolfi & Stephen D. Nimer. (2008) Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes. Clinical Cancer Research 14:3, pages 826-832.
Crossref
Ko Sasaki, Tetsuya Yamagata & Kinuko Mitani. (2008) Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera. Cancer Science 99:2, pages 414-422.
Crossref
Lei Wang & Chih-Cheng Tsai. (2008) Atrophin Proteins: An Overview of a New Class of Nuclear Receptor Corepressors. Nuclear Receptor Signaling 6:1, pages nrs.06009.
Crossref
Robert Hines, Anita Boyapati & Dong-Er Zhang. (2007) Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO. Blood Cells, Molecules, and Diseases 39:3, pages 297-306.
Crossref
P Karagianni & J Wong. (2007) HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 26:37, pages 5439-5449.
Crossref
Luke F. Peterson, Anita Boyapati, Eun-Young Ahn, Joseph R. Biggs, Akiko Joo Okumura, Miao-Chia Lo, Ming Yan & Dong-Er Zhang. (2007) Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts. Blood 110:3, pages 799-805.
Crossref
Y Tabe, L Jin, R Contractor, D Gold, P Ruvolo, S Radke, Y Xu, Y Tsutusmi-Ishii, K Miyake, N Miyake, S Kondo, A Ohsaka, I Nagaoka, M Andreeff & M Konopleva. (2007) Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death & Differentiation 14:8, pages 1443-1456.
Crossref
Shizuka Imagama, Akihiro Abe, Momoko Suzuki, Fumihiko Hayakawa, Akira Katsumi, Nobuhiko Emi, Hitoshi Kiyoi & Tomoki Naoe. (2007) LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22). European Journal of Haematology 79:1, pages 25-31.
Crossref
Yufeng Wei, Shaohua Liu, Jörn Lausen, Christopher Woodrell, Seongeun Cho, Nikolaos Biris, Naohiro Kobayashi, Yu Wei, Shigeyuki Yokoyama & Milton H Werner. (2007) A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription. Nature Structural & Molecular Biology 14:7, pages 653-661.
Crossref
Yizhou Liu, Wei Chen, Justin Gaudet, Matthew D. Cheney, Liya Roudaia, Tomasz Cierpicki, Rachel C. Klet, Kari Hartman, Thomas M. Laue, Nancy A. Speck & John H. Bushweller. (2007) Structural Basis for Recognition of SMRT/N-CoR by the MYND Domain and Its Contribution to AML1/ETO's Activity. Cancer Cell 11:6, pages 483-497.
Crossref
Francesco Fazi, Giuseppe ZardoVania Gelmetti, Lorena Travaglini, Alberto Ciolfi, Luciano Di CroceAlessandro RosaIrene BozzoniFrancesco GrignaniFrancesco Lo-Coco, Pier Giuseppe PelicciClara Nervi. (2007) Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 109:10, pages 4432-4440.
Crossref
Ivana GojoAnchalee JiemjitJane B. Trepel, Alex Sparreboom, William D. Figg, Sandra RollinsMichael L. TidwellJacqueline GreerEun Joo Chung, Min-Jung Lee, Steven D. GoreEdward A. SausvilleJames Zwiebel & Judith E. Karp. (2006) Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias. Blood 109:7, pages 2781-2790.
Crossref
Tobias Berg, Yalin Guo, Mahmoud Abdelkarim, Manfred Fliegauf & Michael Lübbert. (2007) Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines. Leukemia Research 31:4, pages 497-506.
Crossref
Christian Wichmann, Linping Chen, Markus Heinrich, Daniela Baus, Edith Pfitzner, Martin Zörnig, Oliver G. Ottmann & Manuel Grez. (2007) Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells. Cancer Research 67:5, pages 2280-2289.
Crossref
G Yang, M A Thompson, S J Brandt & S W Hiebert. (2006) Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein. Oncogene 26:1, pages 91-101.
Crossref
Jong-Soo Lee. (2007) Activation of ATM-dependent DNA Damage Signal Pathway by a Histone Deacetylase Inhibitor, Trichostatin A. Cancer Research and Treatment 39:3, pages 125.
Crossref
Jong-Soo Lee. (2007) Functional Link between DNA Damage Responses and Transcriptional Regulation by ATM in Response to a Histone Deacetylase Inhibitor TSA. Cancer Research and Treatment 39:3, pages 116.
Crossref
Alan D. Friedman. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 27 42 .
Maria Thomas, Natalia Martínez Soria & Olaf Heidenreich. 2007. Systems Biology. Systems Biology 29 48 .

Displaying 200 of 384 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.